FWBI Entero Therapeutics, Inc.

Nasdaq www.enterothera.com


$ 2.41 $ -0.59 (-19.16 %)    

Thursday, 20-Nov-2025 15:00:15 EST
QQQ $ 585.54 $ -14.20 (-2.37 %)
DIA $ 458.16 $ -3.66 (-0.79 %)
SPY $ 652.51 $ -10.10 (-1.52 %)
TLT $ 89.25 $ 0.35 (0.39 %)
GLD $ 374.59 $ -0.11 (-0.03 %)
$ 2.49
$ 2.88
$ 2.45 x 300
$ 2.56 x 100
$ 2.42 - $ 2.90
$ 0.97 - $ 5.84
133,528
na
8.37M
$ 1.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-19-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-15-2025 03-31-2025 10-Q
4 04-01-2025 12-31-2024 10-K
5 11-13-2024 09-30-2024 10-Q
6 10-21-2024 06-30-2024 10-Q
7 05-14-2024 03-31-2024 10-Q
8 03-29-2024 12-31-2023 10-K
9 11-13-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 05-12-2023 03-31-2023 10-Q
12 03-20-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-15-2022 06-30-2022 10-Q
15 05-23-2022 03-31-2022 10-Q
16 03-31-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-16-2021 06-30-2021 10-Q
19 05-24-2021 03-31-2021 10-Q
20 03-31-2021 12-31-2020 10-K
21 11-16-2020 09-30-2020 10-Q
22 08-14-2020 06-30-2020 10-Q
23 05-15-2020 03-31-2020 10-Q
24 03-30-2020 12-31-2019 10-K
25 11-14-2019 09-30-2019 10-Q
26 08-13-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
28 04-01-2019 12-31-2018 10-K
29 11-09-2018 09-30-2018 10-Q
30 08-13-2018 06-30-2018 10-Q
31 05-14-2018 03-31-2018 10-Q
32 03-16-2018 12-31-2017 10-K
33 11-13-2017 09-30-2017 10-Q
34 08-14-2017 06-30-2017 10-Q
35 05-15-2017 03-31-2017 10-Q
36 03-31-2017 12-31-2016 10-K
37 11-25-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

 Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) (NASDAQ:ENTO) ("Entero" or the "Company"), a l...

 first-wave-biopharma-announces-11m-registered-direct-offering-of-366000-shares-of-common-stock-at-a-price-of-295share-priced-at-the-market

First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a clinical-stage biopharm...

 hc-wainwright--co-reinstates-neutral-on-first-wave-biopharma

HC Wainwright & Co. analyst Yi Chen reinstates First Wave BioPharma (NASDAQ:FWBI) with a Neutral.

 roth-mkm-maintains-buy-on-first-wave-biopharma-lowers-price-target-to-36

Roth MKM analyst Jonathan Aschoff maintains First Wave BioPharma (NASDAQ:FWBI) with a Buy and lowers the price target from $...

 why-limbach-holdings-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarte...

 first-wave-biopharma-completes-merger-deal-with-immunogenx-adding-phase-3-ready-candidate-for-celiac-disease

First Wave BioPharma acquires ImmunogenX, focusing on advancing GI pipeline. James Sapirstein remains Chairman & CEO, with ...

 first-wave-biopharma-inc-to-raise-4m-of-gross-proceeds-in-registered-direct-offering-of-525625-shares-of-common-stock-at-a-price-of-761-per-share

First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a clinical-stage biopharm...

 why-mobileye-global-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23...

 why-resources-connection-shares-are-trading-higher-by-over-6-here-are-20-stocks-moving-premarket

Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results f...

 whats-going-on-with-first-wave-biopharma-stock

First Wave BioPharma, Inc. (NASDAQ: FWBI) shares are trading higher Wednesday.  What To Know:

 roth-mkm-maintains-buy-on-first-wave-biopharma-adjusts-price-target-to-40

Roth MKM analyst Jonathan Aschoff maintains First Wave BioPharma (NASDAQ:FWBI) with a Buy, adjusts target to $40 from $11.

 why-sofi-technologies-shares-are-trading-lower-by-around-13-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods dow...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION